CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205,247 | -53.6% | 6,540 | -67.1% | 0.00% | -33.3% |
| Q2 2023 | $442,664 | -37.1% | 19,895 | -38.8% | 0.00% | -50.0% |
| Q1 2023 | $704,210 | +84.2% | 32,512 | +72.7% | 0.01% | +100.0% |
| Q4 2022 | $382,336 | -31.1% | 18,825 | -13.1% | 0.00% | -40.0% |
| Q3 2022 | $555,000 | +5.9% | 21,659 | -1.7% | 0.01% | +25.0% |
| Q2 2022 | $524,000 | -3.0% | 22,028 | -8.1% | 0.00% | +33.3% |
| Q1 2022 | $540,000 | +24.7% | 23,976 | +9.7% | 0.00% | +50.0% |
| Q4 2021 | $433,000 | -65.6% | 21,860 | -65.8% | 0.00% | -75.0% |
| Q3 2021 | $1,259,000 | +152.8% | 63,980 | +182.5% | 0.01% | +166.7% |
| Q2 2021 | $498,000 | -13.4% | 22,649 | -6.3% | 0.00% | -25.0% |
| Q1 2021 | $575,000 | -51.5% | 24,170 | -46.7% | 0.00% | -42.9% |
| Q4 2020 | $1,186,000 | +562.6% | 45,337 | +341.3% | 0.01% | +600.0% |
| Q3 2020 | $179,000 | -31.4% | 10,273 | -33.8% | 0.00% | -50.0% |
| Q2 2020 | $261,000 | +24.3% | 15,528 | -10.3% | 0.00% | 0.0% |
| Q4 2019 | $210,000 | -10.3% | 17,319 | +4.8% | 0.00% | 0.0% |
| Q3 2019 | $234,000 | -3.3% | 16,533 | -23.8% | 0.00% | 0.0% |
| Q2 2019 | $242,000 | -40.2% | 21,703 | -37.1% | 0.00% | -33.3% |
| Q1 2019 | $405,000 | -36.4% | 34,480 | -27.8% | 0.00% | -40.0% |
| Q4 2018 | $637,000 | -57.4% | 47,729 | -55.3% | 0.01% | -50.0% |
| Q3 2018 | $1,497,000 | +7.5% | 106,778 | +20.6% | 0.01% | +11.1% |
| Q2 2018 | $1,393,000 | -64.5% | 88,542 | -62.9% | 0.01% | -10.0% |
| Q1 2018 | $3,924,000 | +2.9% | 238,451 | +12.9% | 0.01% | +11.1% |
| Q4 2017 | $3,813,000 | +1690.1% | 211,127 | +986.0% | 0.01% | +800.0% |
| Q1 2017 | $213,000 | +10.4% | 19,441 | -26.9% | 0.00% | 0.0% |
| Q4 2016 | $193,000 | +4.9% | 26,588 | -6.2% | 0.00% | 0.0% |
| Q3 2016 | $184,000 | +12.9% | 28,343 | -4.9% | 0.00% | 0.0% |
| Q2 2016 | $163,000 | +23.5% | 29,791 | +5.3% | 0.00% | – |
| Q1 2016 | $132,000 | – | 28,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |